World · India Bureau
Doctor defends use of generic drugs in SMA treatment at SAT Hospital
A senior physician at SAT Hospital's Spinal Muscular Atrophy clinic has stated that parents of affected children were adequately informed about the use of generic medications as part of their treatment protocol.
LSN India ·
The doctor in charge of the Spinal Muscular Atrophy (SMA) clinic at SAT Hospital has responded to concerns about treatment options by clarifying that parents were provided proper counselling regarding the use of generic drugs. The assertion comes amid ongoing discussions about therapeutic choices available for children diagnosed with the rare genetic disorder.
According to the clinic head, the decision to use generic formulations was part of a transparent treatment approach aimed at making care accessible to affected families. The medical team reportedly discussed the efficacy, safety profile, and cost implications of generic alternatives compared to branded counterparts during parent consultations.
Spinal Muscular Atrophy is a rare neuromuscular disorder that affects motor neurons, leading to progressive muscle weakness. Treatment options have expanded in recent years, though access to certain therapies remains limited due to cost and availability constraints in many regions.
The hospital official's statement suggests that informed consent protocols were followed in line with medical ethics guidelines. The clinic continues to manage SMA cases through a combination of genetic counselling, symptomatic management, and appropriate pharmacological interventions tailored to individual patient needs.
The clarification underscores the importance of transparent communication between medical providers and families when navigating treatment decisions for complex genetic conditions, particularly where multiple therapeutic options exist at varying price points.